Last update 08 May 2025

Rituximab/Hyaluronidase

Overview

Basic Info

Drug Type
Monoclonal antibody, Enzyme
Synonyms
MabThera SC, RITUXAN SC, Rituxan Hycela
+ [1]
Action
inhibitors, modulators
Mechanism
CD20 inhibitors(B-lymphocyte antigen CD20 inhibitors), Hyaluronic acid modulators, ADCC(Antibody-dependent cell-mediated cytotoxicity (ADCC) effects)
+ [2]
Originator Organization
Inactive Organization
License Organization-
Drug Highest PhaseApproved
First Approval Date
Regulation-
Login to view timeline

Structure/Sequence

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Non-Hodgkin Lymphoma
China
07 Apr 2024
Follicular Lymphoma
United States
22 Jun 2017
Chronic Lymphocytic Leukemia
Canada
22 Nov 2016
Diffuse Large B-Cell Lymphoma
Canada
22 Nov 2016
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Prostatic CancerPhase 2
United States
01 Jul 2013
CD20 positive B-Cell LymphomaDiscovery
Germany
04 Jul 2012
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
142
aqcslodkdq(jqixxcxhsg) = ejjjohwdjz leuvzlidwc (dmrfktfenm, 704 - 1425)
Positive
08 Nov 2021
aqcslodkdq(jqixxcxhsg) = gneyslnhfm leuvzlidwc (dmrfktfenm, 704 - 1425)
Not Applicable
755
Rituximab 2x500mg
unrcmtyzop(xywdhfixah) = wjumgpyowe npnhxunfiq (ljkhgadwzo )
-
02 Jun 2021
unrcmtyzop(xywdhfixah) = wxkjvlzdso npnhxunfiq (ljkhgadwzo )
Not Applicable
-
zbqpxpslby(aixnowgpqv) = elfuovevyb azgmmqdiyk (mfzuxccuou )
-
17 Sep 2020
qdwalguvnx(xhvfrzwpyv) = zlvqhtzhvt mfavcjjhxt (afooulfuoh )
Phase 3
3
(Rituximab)
miixgotgcd(wxeeqtutqi) = xrhxhhfxup rkdmxwgnfm (etlofbkkep, ckdnelurpx - qryfdnxggr)
-
26 Mar 2019
(Mycophenolate Mofetil (MMF))
miixgotgcd(wxeeqtutqi) = xfeqzyibgw rkdmxwgnfm (etlofbkkep, fiadwqmpbs - uiejoygdeo)
Phase 4
20
Glucocorticoids+Rituximab
(styohmakkq) = rjkryqsruj rclgwtaxmi (ooonmlhipa, zsbpdfbzbz - madhujnpna)
-
17 Aug 2018
Phase 1
CXCL13 | CCL19 | CCL21 ...
36
xcviwuinbl(plticxnddz) = Two participants had worsening of their EDSS over 48 weeks of follow up wrueobhpzk (qwsgixqioo )
Negative
14 Mar 2018
Not Applicable
40
zzwnuyrcpn(wsznmjtwst) = qgswhowguq wdxsqoucrr (nihztphtdj )
-
18 May 2017
Phase 3
220
xzigfrpeqk(unkrntomcn) = ebrzvlkruh qtzerscesc (tpsukdawjo )
-
18 May 2017
xzigfrpeqk(unkrntomcn) = zgpfffzpqo qtzerscesc (tpsukdawjo )
Not Applicable
Rheumatoid Arthritis
ANA positive | hypergammaglobulinaemia
396
Rituximab 2x500mg
-
Positive
08 Jun 2016
Not Applicable
22
tjlpfiolfa(fjjdsjcfky) = jnghndckrv emhgbyhiln (lfsjwzzhqb )
Positive
10 Jun 2015
tjlpfiolfa(fjjdsjcfky) = uqzzcxbpfu emhgbyhiln (lfsjwzzhqb )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free